These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9873130)

  • 1. [Correlation between 99m Tc-tetrofosmin uptake and P-glycoprotein expression in non-small-cell lung cancer].
    Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
    Rev Esp Med Nucl; 1998; 17(6):427-34. PubMed ID: 9873130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of pulmonary lesions with (99m)Tc-Tetrafosmin and chest spect. Determination of uptake related factors, diagnostic value and prognosis].
    Tabuenca MJ; Vargas JA; Castejón R; Varela A; Salas C; Ramón Y Cajal S; Durántez A; Ortiz-Berrocal J
    Rev Esp Med Nucl; 2002 Apr; 21(2):99-108. PubMed ID: 11879618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
    Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
    Lung; 2003; 181(2):103-11. PubMed ID: 12953149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
    Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
    Lung; 2001; 179(4):197-207. PubMed ID: 11891611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of Tc-99m tetrofosmin scintimammography in the assessment of P-glycoprotein in patients with breast cancer.
    Silov G; Erdoğan Z; Özdal A; Tutuş A; Tekin Y; Karaman H; Turhal Ö
    Hell J Nucl Med; 2013; 16(3):218-22. PubMed ID: 24137583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
    Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
    Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
    Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
    Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between 99mTc-tetrofosmin uptake and P-glycoprotein in non-small cell lung cancer.
    Tabuenca MJ; Vargas JA; Varela A; Salas C; Ramón y Cajal S; Durántez A; Berrocal JO
    J Nucl Med; 1999 Jul; 40(7):1223-5. PubMed ID: 10405147
    [No Abstract]   [Full Text] [Related]  

  • 10. Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Changlai SP; Lee JK
    J Nucl Med; 2001 Jan; 42(1):17-20. PubMed ID: 11197970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
    J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
    Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
    Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
    Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-tetrofosmin SPECT imaging of lung masses: a negative study.
    Kao CH; ChangLai SP; Shen YY; Lee JK; Wang SJ
    J Nucl Med; 1997 Jul; 38(7):1015-9. PubMed ID: 9225781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
    Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
    Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chemotherapy response in patients with small cell lung cancer using Technetium-99m-tetrofosmin.
    Kao CH; Ho YJ; Shen YY; Lee JK
    Anticancer Res; 1999; 19(3B):2311-5. PubMed ID: 10472350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of single photon emission computed tomography of the liver with technetium-99m tetrofosmin to detect hepatocellular carcinoma.
    Ho YJ; Jeng LB; Yang MD; Kao CH; Lin CC; Lee CC
    Anticancer Res; 2003; 23(2C):1743-6. PubMed ID: 12820451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer.
    Kostakoglu L; Kiratli P; Ruacan S; Hayran M; Emri S; Ergün EL; Bekdik CF
    J Nucl Med; 1998 Feb; 39(2):228-34. PubMed ID: 9476923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
    Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF
    J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.